Signpath Pharma Competitors and Similar CompaniesClear all
Nektar Therapeutics's competitors and similar companies include CureVac and Exelixis.
Founding Date | Founding Date 1990 | Founding Date 2000 | Founding Date 1994 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Alameda, US HQ |
Employees | Employees 61821% increase | Employees 82517% decrease | Employees 1,14712% decrease |
Valuation ($) | Valuation ($) 233.8 m | Valuation ($) 648.3 m | Valuation ($) 8.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) $55.2m (FY, 2025) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) $2.3b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €9.7m (FY, 2024) | Cost of goods $83.7m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €534.4m (FY, 2024) | Gross profit $2.2b (FY, 2025) |
Net income | Net income ($164.1m) (FY, 2025) | Net income €162.2m (FY, 2024) | Net income $782.6m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 45m | Total funding raised $ 1.1b | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View company
Exelixis
HQ
Alameda, US
Employees
1,147↓ 12% decrease
Exelixis is an oncology company that develops cancer treatments.
View company